Allspring Global Investments
LAB icon

Allspring Global Investments’s Standard BioTools LAB Stock Holding History

Allspring Global Investments’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,462
Closed -$36K – 2928
2022
Q3 		$36K Buy
33,462
+9,912
+42% +$15K ﹤0.01% 2464
2022
Q2 		$37K Buy
+23,550
New +$58.3K ﹤0.01% 2337

Other funds holding LAB

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JCP
Jennifer C. Price $75.5M AUM 6.25% 1-Year Est. Return

Allspring Global Investments's LAB Position: Q4 2022 in Review

Allspring Global Investments sold out of Standard BioTools (LAB) in Q4 2022, closing a stake of 33,462 shares — an estimated $36K sold.

Allspring Global Investments first reported a position in LAB in Q2 2022 and held it in 2 quarters. The position peaked at $37K in Q2 2022. 68 funds tracked by Wall St. Rank hold LAB as of Q4 2022.

  • Allspring Global Investments reported no remaining Standard BioTools position as of Q4 2022 after selling out during the quarter.
  • Allspring Global Investments sold 33,462 Standard BioTools shares in Q4 2022, an estimated $36K.
  • Allspring Global Investments first reported a position in Standard BioTools in Q2 2022 and held it in 2 quarters.
  • Allspring Global Investments's Standard BioTools position peaked at $37K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2022.

Based on Allspring Global Investments's 13F filing for Q4 2022, filed 23 Jan 2023.